Driving performance in patients with chronic liver disease.

被引：0
|
作者：
Hassanein, TI
Hilsabeck, RC
Marcott, TD
Carlson, MD
Perry, W
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
541
引用
收藏
页码：419A / 419A
页数：1
相关论文
共 50 条
  • [1] Tumor markers in patients with chronic liver disease.
    Zuckerman, E
    Levenstein, L
    Lanir, A
    Sabo, E
    Slobodin, G
    Keren, D
    Yeshurun, D
    HEPATOLOGY, 1999, 30 (04) : 433A - 433A
  • [2] Pharmacokinetics of hepapoietin in patients with chronic liver disease.
    Marino, G
    Rustgi, VK
    Flockard, D
    Kuo, PC
    Plotkin, JS
    Johnson, LB
    Islam, K
    GASTROENTEROLOGY, 2000, 118 (04) : A1466 - A1466
  • [3] Patients with chronic liver disease. Are they naturally anticoagulated?
    Tripodi, Armando
    Mannucci, Pier Mannuccio
    THROMBOSIS RESEARCH, 2022, 218 : 1 - 4
  • [4] Adherence to vaccination guidelines in patients with chronic liver disease.
    Arguedas, MR
    McGuire, BM
    Fallon, MB
    Abrams, GA
    Bloomer, JR
    HEPATOLOGY, 2000, 32 (04) : 314A - 314A
  • [5] Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease.
    Satoi, J
    Sanjyou, Y
    Takekuma, A
    Nekohashi, T
    Abe, T
    Tsuboi, Y
    Suzuki, N
    Kato, T
    Tahara, T
    Tanaka, T
    HEPATOLOGY, 1997, 26 (04) : 309 - 309
  • [6] Ghrelin is a parameter of catabolism in patients with chronic liver disease.
    Tacke, F
    Brabant, G
    Kruck, E
    Horn, R
    Schöffski, P
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 530A - 530A
  • [7] Medication adherence evaluation in patients with chronic liver disease.
    Culafic, Milica
    Kovacevic, Sandra Vezmar
    Gosnjic, Nikola
    Filipovic, Marina
    Vucicevic, Katarina
    Miljkovic, Branislava
    Culafic, Djordje
    PHARMACOTHERAPY, 2017, 37 (06): : E45 - E45
  • [8] Osteoporosis in chronic liver disease.
    Heathcote J.
    Current Gastroenterology Reports, 1999, 1 (6) : 455 - 458
  • [9] Safety and immunogenicity of hepatitis a vaccine in patients with chronic liver disease.
    Keeffe, EB
    McMahon, BJ
    Koff, RS
    Lindsay, KL
    Manns, M
    Ivarson, S
    Baumgarten, R
    Wiese, M
    Krause, DS
    Fourneau, M
    Safary, A
    Clemens, R
    GASTROENTEROLOGY, 1996, 110 (04) : A1231 - A1231
  • [10] Alcohol use in patients with newly diagnosed chronic liver disease.
    Navarro, VJ
    St Louis, TE
    Benner, KG
    Zaman, A
    Ivie, KB
    Bell, BP
    HEPATOLOGY, 2000, 32 (04) : 424A - 424A
12345